419 related articles for article (PubMed ID: 27463117)
1. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.
Someya F; Mugii N; Oohata S
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):152-156. PubMed ID: 27463117
[TBL] [Abstract][Full Text] [Related]
2. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
3. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
[TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary factors affecting 6-min walk distance in patients with idiopathic inflammatory myopathies.
Mugii N; Someya F
Rheumatol Int; 2018 Aug; 38(8):1443-1448. PubMed ID: 29761224
[TBL] [Abstract][Full Text] [Related]
5. The relationship between global longitudinal strain and pulmonary function tests in patients with scleroderma and normal ejection fraction and pulmonary artery pressure: a case-control study.
Hajsadeghi S; Mirshafiee S; Pazoki M; Moradians V; Mansouri P; Kianmehr N; Iranpour A
Int J Cardiovasc Imaging; 2020 May; 36(5):883-888. PubMed ID: 32060775
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).
Kusunose K; Yamada H; Nishio S; Hirata Y; Seno H; Saijo Y; Ise T; Tobiume T; Yamaguchi K; Yagi S; Soeki T; Wakatsuki T; Sata M
Am J Cardiol; 2017 Jul; 120(2):315-321. PubMed ID: 28532772
[TBL] [Abstract][Full Text] [Related]
7. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension.
Andrade FM; Oliveira AD; Lopes AJ
Braz J Med Biol Res; 2019; 52(8):e8513. PubMed ID: 31365695
[TBL] [Abstract][Full Text] [Related]
8. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.
Someya F; Mugii N; Hasegawa M; Yahata T; Nakagawa T
Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864
[TBL] [Abstract][Full Text] [Related]
9. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of six-minute walk test in systemic sclerosis.
Rizzi M; Radovanovic D; Santus P; Airoldi A; Frassanito F; Vanni S; Cristiano A; Sarzi-Puttini P; Atzeni F
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):161-167. PubMed ID: 30277863
[TBL] [Abstract][Full Text] [Related]
11. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test.
Buch MH; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells AU; Matucci-Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM; Seibold JR
Ann Rheum Dis; 2007 Feb; 66(2):169-73. PubMed ID: 16868020
[TBL] [Abstract][Full Text] [Related]
12. A study on pulmonary complications of systemic sclerosis in eastern India.
Ghosh A; Banerjee A; Biswas AK
Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
[TBL] [Abstract][Full Text] [Related]
13. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
[TBL] [Abstract][Full Text] [Related]
14. Value of impedance cardiography during 6-minute walk test in pulmonary hypertension.
Tonelli AR; Alkukhun L; Arelli V; Ramos J; Newman J; McCarthy K; Pichurko B; Minai OA; Dweik RA
Clin Transl Sci; 2013 Dec; 6(6):474-80. PubMed ID: 24330692
[TBL] [Abstract][Full Text] [Related]
15. Ability of the COPD Assessment Test to evaluate the lung-specific quality of life in systemic sclerosis-associated interstitial lung disease.
Mugii N; Someya F
Clin Respir J; 2020 Jun; 14(6):527-532. PubMed ID: 32045097
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with the 6-minute walk distance in patients with systemic sclerosis.
Sanges S; Giovannelli J; Sobanski V; Morell-Dubois S; Maillard H; Lambert M; Podevin C; Lamblin N; De Groote P; Bervar JF; Perez T; Matran R; Rémy-Jardin M; Hatron PY; Hachulla É; Launay D
Arthritis Res Ther; 2017 Dec; 19(1):279. PubMed ID: 29246248
[TBL] [Abstract][Full Text] [Related]
17. Cardiac hemodynamic response to the 6-minute walk test in young adults and the elderly.
Someya F; Mugii N; Oohata S
BMC Res Notes; 2015 Aug; 8():355. PubMed ID: 26283665
[TBL] [Abstract][Full Text] [Related]
18. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.
Miyamoto S; Nagaya N; Satoh T; Kyotani S; Sakamaki F; Fujita M; Nakanishi N; Miyatake K
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):487-92. PubMed ID: 10673190
[TBL] [Abstract][Full Text] [Related]
19. Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables.
Rosato E; Romaniello A; Magrì D; Bonini M; Sardo L; Gigante A; Quarta S; Digiulio MA; Viola G; Di Paolo M; Jacoangeli F; Baiocchi P; Salsano F; Palange P
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-103-8. PubMed ID: 25372795
[TBL] [Abstract][Full Text] [Related]
20. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
